| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5 |
| P698 | PubMed publication ID | 11409666 |
| P50 | author | Justine Smith | Q71908832 |
| P2093 | author name string | Jabs DA | |
| Rosenbaum JT | |||
| Levinson RD | |||
| Robinson MR | |||
| Holland GN | |||
| Whitcup SM | |||
| P433 | issue | 3 | |
| P921 | main subject | rheumatism | Q684924 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 252-257 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease | |
| P478 | volume | 45 |
| Q95359201 | Q95359201 |
| Q37823308 | Adalimumab (humira™) in ophthalmology: a review of the literature |
| Q37146227 | Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study |
| Q48625167 | Adalimumab for juvenile idiopathic arthritis-associated uveitis. |
| Q35763157 | Adalimumab in the therapy of uveitis in childhood |
| Q90241578 | Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders |
| Q26849811 | Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis |
| Q35593155 | Anti-TNF-alpha therapy for sight threatening uveitis |
| Q52902407 | Anti-TNF-α Treatment: A Possible Promoter in Endogenous Uveitis? Observational Report on Six Patients: Occurrence of Uveitis Following Etanercept Treatment |
| Q60207426 | Anti-TNF-α therapy for uveitis: Behçet and beyond |
| Q40617558 | Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis |
| Q34648346 | Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management |
| Q35146003 | Arthritis and uveitis in children. A pediatric rheumatology perspective |
| Q37208980 | Biologic agents in the management of inflammatory eye diseases |
| Q38576234 | Biologic therapy for refractory scleritis: a new treatment perspective |
| Q42714905 | Challenges of childhood uveitis |
| Q41335660 | Clinical features of psoriatic uveitis in Japanese patients |
| Q35112336 | Clinical research helps elucidate the role of tumor necrosis factor-αin the pathogenesis of T1-mediated immune disorders: use of targeted immunotherapeutics as pathogenic probes |
| Q35580562 | Clinical trials in pediatric uveitis |
| Q83815516 | Comment to the article: infliximab for treating sarcoidosis patients, Portuguese experience |
| Q57171464 | Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative |
| Q35828102 | Corticosteroid-sparing therapy: practice patterns among uveitis specialists |
| Q37007652 | Current perspectives on ophthalmic manifestations of childhood rheumatic diseases |
| Q26852585 | Cytokines and Biologics in non-infectious autoimmune uveitis: bench to bedside |
| Q35174889 | Cytokines and immunopathogenesis of intraocular posterior segment inflammation |
| Q34993224 | Cytokines in immunotherapy of experimental uveitis |
| Q64943511 | Diagnosis and treatment of uveitis; not restricted to the ophthalmologist. |
| Q43013543 | Diseases of the outer eye in rheumatoid arthritis |
| Q43008546 | Does etanercept induce uveitis? |
| Q41592241 | Effect of Systemic Infliximab Therapy in Patients with Sjögren's Syndrome |
| Q47378653 | Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis: A systematic literature review |
| Q35582795 | HLA-B27???associated uveitis: overview and current perspectives |
| Q34274950 | Immunotherapeutic strategies in autoimmune uveitis |
| Q35909794 | Impact of IL-1 signalling on experimental uveitis and arthritis |
| Q41978820 | Impact of ghrelin on vitreous cytokine levels in an experimental uveitis model. |
| Q38283034 | Infliximab for peripheral ulcerative keratitis treatment. |
| Q44516164 | Infliximab in the treatment of refractory posterior uveitis |
| Q35730023 | Interferon-γ regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondylarthritis |
| Q38779665 | Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis |
| Q36055455 | Management of sight-threatening uveitis: new therapeutic options. |
| Q34574284 | Management of uveitis in pediatric patients: special considerations |
| Q34526831 | Management of uveitis: a rheumatologic perspective |
| Q44078484 | Multiple bilateral eyelid molluscum contagiosum lesions associated with TNFalpha-antibody and methotrexate therapy |
| Q36084943 | Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis |
| Q46565241 | News on therapies for uveitis |
| Q37535944 | Non-infectious pediatric uveitis: an update on immunomodulatory management |
| Q36676241 | Ocular complications of childhood rheumatic diseases: uveitis |
| Q38169978 | Ocular inflammatory diseases associated with rheumatoid arthritis. |
| Q34274075 | Pharmacotherapy for uveitis: current management and emerging therapy |
| Q37466204 | Pharmacotherapy of scleritis: current paradigms and future directions |
| Q35813439 | Prevalence of eye disease in Brazilian patients with psoriatic arthritis |
| Q38812551 | Principles of Ocular Pharmacology |
| Q42840715 | Reconsidering treatment options in childhood uveitis |
| Q34789195 | Response of pediatric uveitis to tumor necrosis factor-α inhibitors |
| Q34655378 | Rheumatoid arthritis-associated corneal ulceration with superimposed infection by methicillin-resistant Staphylococcus aureus: a complicated type of corneal melt |
| Q33255239 | Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis |
| Q35145997 | Special considerations in the evaluation and management of uveitis in children |
| Q27025862 | The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis |
| Q34867606 | The expression of STAT-1 and phosphorylated STAT-1 in conjunctival granulomas |
| Q73248407 | Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis |
| Q36775251 | Therapy insight: scleritis and its relationship to systemic autoimmune disease. |
| Q24806367 | Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches |
| Q38755418 | Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization |
| Q45988573 | Treating refractory scleritis with infliximab. |
| Q35902397 | Treatment of ocular inflammation in children |
| Q34965097 | Treatment of rheumatic diseases in children: special considerations. |
| Q44798829 | Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis |
| Q35582517 | Tumour Necrosis Factor in Sarcoidosis and its Potential for Targeted Therapy |
| Q89705076 | Two cases of perforated corneal ulcers complicating rheumatoid arthritis treated successfully by biological therapy |
| Q41984399 | Update on peripheral ulcerative keratitis |
| Q35582804 | Use of immunosuppressive agents in uveitis |
| Q42410303 | Use of infliximab in juvenile onset rheumatological disease-associated refractory uveitis: efficacy in joint and ocular disease |
| Q43009805 | Uveitis and juvenile arthritis |
| Q36174993 | Uveitis, the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT), and intravitreal biologics for ocular inflammation |
| Q35591193 | Visual loss in uveitis of childhood |
| Q84599955 | [Extra-articular manifestations and complications of ankylosing spondylitis] |
| Q84396718 | [Ocular involvement in spondyloarthropathies: HLA B27 associated uveitis] |
| Q81685681 | [Optic neuritis associated with infliximab] |
| Q85356644 | [Psoriasis-associated keratitis: case report] |
| Q81359089 | [TNFalpha inhibitors in the treatment of uveitis] |
| Q83475351 | [Therapy for childhood uveitis: biologics: too often--too late?] |
| Q52939842 | [Uveitis in conjunction with rheumatological diseases in childhood]. |
Search more.